Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy
Open Access
- 11 May 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 11 (4) , 883-887
Abstract
Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, anti-HMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.Keywords
This publication has 12 references indexed in Scilit:
- Dengue infection triggered immune mediated necrotizing myopathy in children: a case report and literature reviewPediatric Rheumatology, 2022
- A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing MyopathyQatar Medical Journal, 2022
- The prevalence and clinical characteristics of anti-HMGCR (anti-3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) antibodies in idiopathic inflammatory myopathy: an analysis from the MyoCite registryRheumatology International, 2022
- Treatment experience of Taiwanese patients with anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase myopathyThe Kaohsiung Journal of Medical Sciences, 2020
- Pediatric anti-HMGCR necrotizing myopathy: diagnostic challenges and literature reviewNeurological Sciences, 2020
- Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathyNeuromuscular Disorders, 2020
- Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroupsAnnals of the Rheumatic Diseases, 2019
- Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophyNeurology Neuroimmunology & Neuroinflammation, 2019
- Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing MyopathyThe Journal of Rheumatology, 2018
- Anti-HMGCR MyopathyJournal of Neuromuscular Diseases, 2018